BIOMAT Database Logo BIOMAT Database Logo

Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy. 1999

T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV

Related Publications

T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Combination antiretroviral therapy in 100 HIV-1-infected pregnant women.
February 2002, Human reproduction (Oxford, England),
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
April 2009, Sexually transmitted infections,
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.
January 2013, Infectious diseases in obstetrics and gynecology,
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.
January 2010, AIDS (London, England),
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy.
November 2011, Journal of perinatal medicine,
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir.
May 2000, AIDS (London, England),
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.
October 2015, AIDS (London, England),
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy.
July 2020, The Journal of clinical investigation,
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Pregnancy outcomes among HIV-infected women undergoing antiretroviral therapy.
March 2009, The open AIDS journal,
T A Grubert, and U Wintergerst, and R Lutz-Friedrich, and B H Belohradsky, and B Rolinski
Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children.
March 1998, AIDS (London, England),
Copied contents to your clipboard!